Previous 10 | Next 10 |
Summary Embecta Corp. signed an agreement with Intuity Medical to sell the POGO device last month. Market is positioning for further upside after Embecta reports its Q4 earnings on December 20th. We see no change to the available market data that suggests we should be sizing in Embe...
Summary SPFF tracks a preferred stock index. It shows an attractive 7% distribution yield. It has lagged at least 4 of its competitors since inception but did well in 2022. It has lost about 35% in share price and 37% in income stream since 2012. Bonus: How to manage capital...
BD Named in top 25% of Newsweek's 2023 List of America's Most Responsible Companies PR Newswire FRANKLIN LAKES, N.J. , Dec. 7, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Although the market has rallied since the start of November, on rising hopes of a pivot on interest rates by the Federal Reserve (aka a “Fed pivot”), that doesn’t necessarily mean it’s time to abando...
BD to Present at Evercore ISI 5th Annual HealthCONx Conference PR Newswire FRANKLIN LAKES, N.J. , Nov. 15, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will prese...
Summary There were a few double-digit boosts in the first half of November. Most notably, ADP came through with a 20% increase and Snap-On Tools with a 14% increase. Emerson extended its dividend growth streak to 66 years with a 1% boost and Lancaster Colony started its 7th decade...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. F...
Becton, Dickinson and Company (BDX) Q4 2022 Earnings Conference Call November 10, 2022 8:00 AM ET Company Participants Francesca DeMartino - SVP & Head, IR Thomas Polen - President, CEO & Chairman Christopher DelOrefice - EVP & CFO Mike Garrison -...
With its Q4 financials for fiscal 2022, COVID-19 test maker Becton, Dickinson ( NYSE: BDX ) exceeded Street forecasts on Thursday, but the company issued a lower-than-expected FY23 guidance citing unfavorable currency impact. Becton, Dickinson ( BDX ) expects its rev...
Becton, Dickinson press release ( NYSE: BDX ): Q4 Non-GAAP EPS of $2.75 beats by $0.01 . Revenue of $4.8B (-1.0% Y/Y) beats by $80M . Company issues FY23 guidance : The company expects fiscal year 2023 revenues to be in the range of approximately $18.6...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...